Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
17-1-1|n/a,n/a|Sequence:1, Age:n/a,Type:X-rays whole body,Quantity:11.7,Unit:grays,Application:External exposure, Remarks:midline 300 kV|8 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|early haemopoietic recovery and haemopoietic function over 2-3 years, age uncertain|No information on individuals available for this study
17-1-1|n/a,n/a|Sequence:2, Age:n/a,Type:autologous Bone marrow transplant,Quantity:,Unit:millions of cells injected,Application:Injection, intravenous, Remarks:autologous 0.32-1.63 billion mononuclear and 2000-138000 GM-CFC cells|8 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|early haemopoietic recovery and haemopoietic function over 2-3 years, age uncertain|No information on individuals available for this study
		
